-
FDA Updates Exjade Adverse Drug Reaction Numbers In Its First Drug-Safety Newsletter
FDA Post-Marketing Safety Review Adds Liver Problems To Previous Reports Of Kidney Failure Associated With Exjade (Posted by Tom Lamb at DrugInjuryWatch.com) In the first edition of FDA Drug Safety Newsletter (Volume 1, Number…
-
Sleep Disorder Narcolepsy Drug Provigil Associated With Serious Skin Reactions
FDA Links Cephalon’s Provigil To Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, And Erythema Multiforme (Posted by Tom Lamb at DrugInjuryWatch.com) According to the Fall 2007 FDA Drug Safety Newsletter (Volume 1, Number 1), which was…
-
FDA To Finally Study Possible Increased Heart Risks Caused By Attention Deficit Medications
The Safety Profile Of Adderall, Concerta, Ritalin, Dexedrine And All Other ADHD / ADD Drugs Will Be Reviewed (Posted by Tom Lamb at DrugInjuryWatch.com) In a September 17, 2007 FDA News article titled "AHRQ…
-
Natrecor Is Associated With Increased Risk Of Acute Renal Failure And Death
Questions About Safety Of Natrecor Continue, With No Apparent Resolution Any Time Soon (Posted by Tom Lamb at DrugInjuryWatch.com) As reported previously, in June 2007 Scios, Inc. announced it had started enrolling patients in…
-
The Use Of Antibiotic Ketek Appears To Significantly Increase Risk Of Liver Damage And Injury
2007 Medical Journal Article Reports That Ketek May Cause A Greater Than 80% Increased Risk Of Hepatotoxicity (Posted by Tom Lamb at DrugInjuryWatch.com) In early September 2007 Health Canada issued a MedEffect alert about…